Literature DB >> 31638229

Downregulation of FSTL‑1 attenuates the inflammation injury during Streptococcus pneumoniae infection by inhibiting the NLRP3 and TLR4/NF‑κB signaling pathway.

Liang Chen1, Zhenshe Liu2.   

Abstract

Streptococcus pneumoniae‑induced pneumonia is a common disease and major cause of community‑acquired pneumonia. Previous studies have shown that Follistatin‑like protein 1 (FSTL‑1) serves important roles in regulating the inflammatory response. The present study aimed to investigate the effect of FSTL‑1 on the inflammatory response during S. pneumoniae infection using in vitro and in vivo models. ELISAs were used to detect the production of interleukin (IL)‑1β, tumor necrosis factor‑α and IL‑6. Western blotting and reverse transcription‑quantitative PCR were performed to determine the protein and mRNA expression of these factors. The results of the present study indicated that S. pneumoniae infection triggered a strong proinflammatory response and a high level of FSTL‑1 expression in mouse bone marrow‑derived macrophages. Moreover, FSTL‑1 may be required for the production of inflammatory factors during S. pneumoniae infection by regulating nucleotide oligomerization domain‑like receptor protein 3 in vitro and in vivo. In addition, it was found that the Toll‑like receptor 4/nuclear factor‑κB signaling pathway was involved in the inflammatory response regulated by FSTL‑1. The findings of the present study suggested that FSTL‑1 plays an important role in the inflammatory response during S. pneumoniae infection, providing a potential therapeutic target for reducing morbidity and mortality in patients with pneumonia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31638229     DOI: 10.3892/mmr.2019.10752

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Follistatin-like 1 ameliorates severe acute pancreatitis associated lung injury via inhibiting the activation of NLRP3 inflammasome and NF-κB pathway.

Authors:  Liming Wang; Na Wang; Guifang Shi; Shuqing Sun
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.

Authors:  Hua Cao; Xinsheng Han; Yonglin Jia; Baohua Zhang
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

3.  Association between follistatin-related protein 1 and the functional status of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Taejun Yoon; Sung Soo Ahn; Jung Yoon Pyo; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Chin Med J (Engl)       Date:  2021-04-14       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.